abstract |
The present invention relates to a pharmaceutical composition for preventing or treating cancer comprising: as active ingredients, (1) an immune checkpoint inhibitor; (2) a biguanide-based compound or a pharmaceutically acceptable salt thereof; (3) 2-deoxy-D-glucose; or further comprising: (4) inositol hexaphosphate or a pharmaceutically acceptable salt thereof, inositol, or a mixture thereof. The compositions according to the present invention not only increase the indicants to various carcinomas for immune checkpoint inhibitors with limited indicants, but also exhibit a synergistic anti-cancer effect by appropriately combining specific drugs, thereby maximizing a therapeutic effect and killing only cancer cells without side effects. Therefore, the compositions of the present invention may be usefully used as anticancer agents for preventing or treating cancer. |